TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05326893 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04214392 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study NCT02310321 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00133536 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00133536 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT03912623 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01847573 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02008110 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04368442 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04144868 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04013880 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03341273 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03818737 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01388647 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01388647 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02081222 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00359853 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00359853 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01043484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01043484 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04074330 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04268992 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT04268992 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04268992 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04268992 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04268992 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT00116792 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00042653 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02415231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01066871 — Predictive Biomarker (PRD): FGF18 mRNA
Genes: FGF18; UNQ420/PRO856
Study NCT01084538 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05218265 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT05218265 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05218265 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00774072 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04231318 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT00305409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00765947 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04059198 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00122772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00878046 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03153345 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01912963 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01257308 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT01257308 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03462069 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03462069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01268202 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study NCT01268202 — Predictive Biomarker (PRD): RHOF mRNA
Genes: RHOF; ARHF; RIF
Study NCT01268202 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT01041729 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02034422 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00499343 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00499343 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02137434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02137434 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06554210 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00004154 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT02761291 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT02761291 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01555437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01555437 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00364130 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01090297 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02293343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00701428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02478125 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02139358 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05767775 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study NCT05767775 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT00006113 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00006113 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00006113 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02755337 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01077206 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00664274 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00295971 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04623385 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT04623385 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04623385 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04623385 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04482738 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04482738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03131453 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00447603 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04211298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04147585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03483285 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00717444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00173576 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03455959 — Safety Biomarker (SAF): Th2 cell
Study NCT01425775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01425775 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00436930 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02779712 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00442819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00442819 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00442819 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00442819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00675077 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03415100 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT03378401 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00120796 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04637906 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03211962 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT03211962 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT00715169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01888653 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT01861522 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01771679 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03893903 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT03893903 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04462848 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00299884 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01236014 — Surrogate Endpoint (SUR): Platelet count response
Study NCT03036059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02433002 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03925168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00633490 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05950165 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02260674 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03045978 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT03045978 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT02871830 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03315182 — Predictive Biomarker (PRD): NAGLU mRNA
Genes: NAGLU; UFHSD1
Study NCT03557853 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02278016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02303834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00214214 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT01796301 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00777335 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03516981 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT02848053 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01258829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02145637 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT02077062 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02077062 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01233310 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03953183 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT01212328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03637790 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03637790 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00415584 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00415584 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02812030 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02812030 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02742090 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02742090 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02725437 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00493506 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01783106 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00590460 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT00590460 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT03271255 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03664817 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01301911 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00001564 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT03005470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05656989 — Predictive Biomarker (PRD): ALPP mRNA
Genes: ALPP; PLAP
Study NCT05656989 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03206255 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00003046 — Safety Biomarker (SAF): Interleukin 12
Study NCT04481464 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT04456010 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00746044 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study NCT00746044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study NCT03114618 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03267329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01260181 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01260181 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01177332 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03494803 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT01068301 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01165801 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04597138 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT02529878 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02529878 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT04083014 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01653197 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04275843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04275843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03959553 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03959553 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00301106 — Safety Biomarker (SAF): Interleukin 12
Study NCT03322462 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03975387 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00515463 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01731691 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02409316 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00938223 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01390688 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01390688 — Safety Biomarker (SAF): BDNF
Study NCT02730208 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00002664 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04750369 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01690234 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00014573 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03412071 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04875364 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02027480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02027480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00790114 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00790114 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT00995865 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00048906 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT02616822 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00234156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00234156 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01542021 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04083222 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT04083222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03776994 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01237288 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04032678 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT02628158 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03265496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02540148 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00790296 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study NCT02014532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01116245 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01961024 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02596347 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03779191 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02089542 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00824460 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03330691 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03330691 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06625164 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02442115 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02852213 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT03511859 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01541878 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01541878 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01541878 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00883584 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01316328 — Predictive Biomarker (PRD): XRCC3 mRNA
Genes: XRCC3
Study NCT01316328 — Predictive Biomarker (PRD): RAD51 mRNA
Genes: RAD51; RAD51A; RECA
Study NCT04279327 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03502707 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02517944 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02517944 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01979601 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04160637 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02401178 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study NCT02401178 — Predictive Biomarker (PRD): FADS2 mRNA
Genes: FADS2
Study NCT01013883 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02104518 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04473976 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study NCT06031467 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT00722345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01507896 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT01643486 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03946358 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03946358 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT03946358 — Predictive Biomarker (PRD): UCP2 mRNA
Genes: UCP2; SLC25A8
Study NCT03946358 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02698761 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05675280 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT02255591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02856074 — Safety Biomarker (SAF): BDNF
Study NCT01633970 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01202110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01884285 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01884285 — Predictive Biomarker (PRD): PIK3CB mRNA
Genes: PIK3CB; PIK3C1
Study NCT02495597 — Predictive Biomarker (PRD): Exhaled nitric oxide